The HDAC inhibitor Panobinostat has been approved by the FDA for the treatment of multiple myeloma, and the DNA methyltransferase inhibitor Decitabine for the treatment of myelodysplastic syndrome30, 31. The gene discussed is HDAC9; the disease is AL amyloidosis.